Profile data is unavailable for this security.
About the company
Daito Pharmaceutical Co., Ltd. is a Japan-based company mainly engaged in the pharmaceutical ingredients and formulation business, as well as healthy food. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.
- Revenue in JPY (TTM)46.90bn
- Net income in JPY3.30bn
- Incorporated1942
- Employees1.07k
- LocationDaito Pharmaceutical Co Ltd326, Yoka-machiTOYAMA-SHI 939-8567JapanJPN
- Phone+81 764215665
- Fax+81 764216006
- Websitehttps://www.daitonet.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stella Pharma Corp | 269.49m | -759.81m | 18.07bn | 44.00 | -- | 6.42 | -- | 67.06 | -24.30 | -24.30 | 8.62 | 82.71 | 0.0594 | 0.0517 | 3.98 | 6,124,796.00 | -16.73 | -22.50 | -17.64 | -24.83 | 80.37 | -- | -281.94 | -488.65 | 15.60 | -943.38 | 0.2481 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.21bn | 19.19bn | 11.00 | -- | 7.73 | -- | -- | -67.63 | -67.63 | 0.00 | 129.88 | 0.00 | -- | -- | 0.00 | -53.54 | -62.25 | -56.62 | -70.91 | -- | -- | -- | -2,015.62 | 25.09 | -- | 0.00 | -- | -- | -- | 2.77 | -- | -- | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.49bn | -2.33bn | 19.75bn | 208.00 | -- | 2.42 | -- | 3.04 | -46.91 | -46.91 | 130.40 | 160.86 | 0.4474 | 1.91 | 3.71 | 31,211,540.00 | -16.07 | -- | -19.68 | -- | 49.37 | -- | -35.92 | -- | 2.95 | -- | 0.2437 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| Astena Holdings Co Ltd | 53.22bn | 2.10bn | 20.90bn | 1.40k | 9.64 | 0.7104 | 4.80 | 0.3927 | 52.92 | 52.92 | 1,343.58 | 717.87 | 0.8105 | 3.42 | 2.73 | 37,904,980.00 | 3.18 | 2.49 | 5.77 | 4.44 | 33.18 | 25.33 | 3.93 | 2.32 | 0.889 | -- | 0.3439 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| StemRIM Inc | 0.00 | -2.02bn | 21.84bn | 44.00 | -- | 2.46 | -- | -- | -32.98 | -32.98 | 0.00 | 144.57 | 0.00 | -- | -- | -- | -20.44 | -8.34 | -20.74 | -8.49 | -- | -- | -- | -68.74 | 131.03 | -11,344.72 | -- | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| Fuso Pharmaceutical Industries Ltd | 56.52bn | 1.53bn | 22.07bn | 1.31k | 13.04 | 0.5354 | 5.86 | 0.3904 | 179.11 | 179.11 | 6,607.60 | 4,361.00 | 0.7454 | 3.08 | 2.35 | 43,245,600.00 | 2.02 | 1.91 | 3.50 | 3.09 | 25.67 | 26.92 | 2.71 | 2.69 | 0.9393 | 36.59 | 0.2767 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| CellSeed Inc | 199.47m | -957.04m | 24.61bn | 35.00 | -- | 11.22 | -- | 123.36 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Fuji Pharma Co Ltd | 44.56bn | 6.36bn | 32.63bn | 1.62k | 5.03 | 0.7128 | 3.31 | 0.7321 | 261.79 | 261.79 | 1,833.31 | 1,849.15 | 0.5156 | 1.40 | 3.15 | 27,490,440.00 | 7.36 | 4.10 | 11.63 | 5.58 | 39.28 | 42.41 | 14.28 | 7.55 | 0.6276 | -- | 0.3912 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
| Daito Pharmaceutical Co Ltd | 46.90bn | 3.30bn | 35.67bn | 1.07k | 11.06 | 0.6826 | 5.22 | 0.7606 | 210.18 | 210.18 | 2,988.66 | 3,404.72 | 0.6326 | 1.89 | 2.96 | 43,827,100.00 | 4.29 | 6.27 | 5.58 | 8.24 | 20.98 | 22.65 | 6.78 | 8.47 | 1.11 | -- | 0.143 | 19.59 | 3.98 | 2.66 | -8.47 | -1.27 | 11.37 | 11.67 |
| Seikagaku Corp | 36.57bn | 2.20bn | 49.14bn | 988.00 | 21.45 | 0.6315 | 12.40 | 1.34 | 40.32 | 40.32 | 670.36 | 1,369.69 | 0.4558 | 2.01 | 4.65 | 37,018,220.00 | 2.74 | 0.4261 | 2.96 | 0.4678 | 47.46 | 54.18 | 6.01 | 0.9814 | 5.04 | -- | 0.0052 | 465.78 | 8.24 | 4.99 | -2.24 | -0.5224 | 30.28 | 0.00 |
Data as of Oct 11 2024. Currency figures normalised to Daito Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
33.60%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kaname Capital LP (Investment Management)as of 19 Jun 2024 | 1.41m | 8.96% |
| MFS International Singapore Pte Ltd.as of 30 Jun 2024 | 696.19k | 4.44% |
| Highclere International Investors LLPas of 07 Jul 2023 | 628.87k | 4.01% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 31 May 2023 | 510.84k | 3.25% |
| Nomura Asset Management Co., Ltd.as of 31 May 2024 | 466.89k | 2.97% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 443.08k | 2.82% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 329.87k | 2.10% |
| Portfolia, Inc.as of 31 Mar 2023 | 312.95k | 1.99% |
| Kuwait Investment Authority (Investment Management)as of 31 May 2023 | 258.83k | 1.65% |
| Ichiyoshi Asset Management Co., Ltd.as of 29 Jun 2022 | 221.10k | 1.41% |
More ▼
Data from 31 Mar 2023 - 08 Aug 2024Source: FactSet Research Systems Inc.
